1. Belgium Stocks

  2. •

    Financial Services

  3. •

    Asset Management
Groupe Bruxelles Lambert S.A.

Groupe Bruxelles Lambert S.A.

GBLB.BR
Groupe Bruxelles Lambert S.A.BE flagEuronext Brussels
77.75
EUR
-0.35
- -
9.29BMarket Cap
Groupe Bruxelles Lambert S.A.
GBLB.BR
(Euronext Brussels)

Recent

price

77.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
4.31
22.18
29.12
26.84
27.26
31.01
31.83
32.08
35.36
35.07
40.76
42.66
41.44
46.64
44.73
50.86
47.08
Revenue per Share
4.11
0.46
1.65
4
5.64
6.61
-2.95
4.53
4.18
4.48
2.53
1.83
-3.99
12.28
0.99
-4.94
-0.79
Basic EPS, GAAP
3.28
3.55
-1.48
2.58
1.43
5.97
1.61
3.95
3.32
4.21
5.63
3.86
1.25
3.32
5.59
0.55
- -
Free Cash Flow per Basic Share
2.42
2.54
2.6
2.65
2.72
2.79
2.86
2.93
3.01
3.08
3.17
2.5
2.73
2.71
2.66
4.9
- -
Dividend per Share
4.21
44.3
42.97
44.88
47.2
51.65
45.9
47.19
4.14
4.16
4.23
4.29
54.38
63.86
68.63
60.1
64.64
Book Value per Share
94.58
79.88
78.45
79.97
83.15
80.27
91.12
96.75
91.2
101.5
100.39
102.02
52.66
75.38
68.71
51.56
55.68
Tangible Book Value per Share
155
155
155
155
155
155
155
156
158
157
154
152
147
140
134
126
129
Basic Weighted Avg Shares
670
3,444
4,521
4,162
4,229
4,815
4,946
4,992
5,575
5,510
6,292
6,491
6,080
6,543
5,971
6,434
6,088
Sales/Revenue/Turnover
95.19
23.29
21.92
16.99
18.8
24.46
19.58
16.84
17.44
18.44
17.19
11
4.96
13.1
4.17
6.13
3.25
Operating Margin (%)
1
169
237
231
235
259
264
297
318
433
539
567
676
693
558
619
588
Depreciation Expense
638
71
256
621
875
1,026
-458
705
659
705
391
279
-585
1,723
132
-625
-103
Net Income, GAAP
- -
35.37
24.06
12.64
10.88
5.83
- -
12.85
44.92
7.8
15.84
14.48
- -
22.44
434.45
- -
19.4
Effective Tax Rate (%)
95.33
2.06
5.65
14.91
20.7
21.32
-9.25
14.13
11.82
12.79
6.21
4.29
-9.62
26.34
2.22
-9.72
-1.69
Profit Margin (%)
712
929
1,900
2,227
2,814
1,799
1,655
612
1,933
2,066
1,901
3,005
2,444
2,223
2,821
4,449
2,738
Working Capital
278
2,321
2,133
3,295
3,230
3,258
2,030
2,626
3,443
5,775
6,255
7,598
10,594
7,492
7,083
7,411
6,223
LT Debt
14,755
13,631
13,392
13,691
14,284
14,544
16,374
17,936
17,630
21,339
20,473
21,788
16,820
17,010
16,125
13,372
14,301
Total Equity
- -
3.28
4.66
3.75
4.07
6.17
- -
3.53
2.48
3.75
3.26
2.11
- -
2.41
-3.31
- -
- -
Return on Invested Capital (%)
- -
0.65
2.14
5.79
7.52
8.98
- -
5.02
5.08
9.75
5.31
2.51
- -
9.19
-5.19
- -
- -
Return on Capital (%)
97.75
1.89
3.77
9.11
12.26
13.38
-6.04
9.75
16.48
107.9
59.87
42.69
-13.55
20.35
1.46
-7.46
-1.19
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
1,241
- -
1,162
LT Borrowings
6,484
- -
5,618
LT Finance Leases
599
- -
605
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
126
- -
123
Market Capitalization
8,540
8,896
9,348

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
5,774
- -
5,733
Cash, Cash Equivalents & STI
3,570
- -
3,374
Accounts Receivable, Net
637
- -
756
Inventories
1,106
- -
1,063
Total Current Liabilities
2,954
- -
2,995
Payables & Accruals
- -
- -
- -
ST Debt
1,241
- -
1,162
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.01%
-7.5%
-17.07%
Free Cash Flow
13.75%
4.32%
-90.76%
Net Income, GAAP
-184.1%
-279.63%
-572.71%
Sales/Revenue/Turnover
3.18%
0.69%
7.75%
Total Cash Common Dividend
5.82%
9.18%
74.48%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,659
1,749
1,548
1,161
5,971
2025
1,673
1,707
1,466
- -
6,434
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.5
- -
- -
- -
0.99
2025
0.73
- -
- -
- -
-4.94
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2.66
2025
- -
- -
- -
- -
4.9
2026
- -
- -
- -
- -
- -
Similar Companies
JPMorgan ETFs (Ireland) ICAV - BetaBuilders US Equity UCITS ETF (BBUD.L)
Blue Owl Technology Finance Corp. (OTF)
FT Vest U.S. Equity Moderate Buffer ETF - January (GJAN)
EAC Invest A/S (EAC.CO)
Royce International Premier Fund (RYIPX)
Healthcare Special Opportunities Fund (MDS-UN.TO)
Business
Groupe Bruxelles Lambert S.A. (GBL) is a leading Belgian investment holding company focused on long-term value creation through a diversified portfolio of listed and private assets. Listed on Euronext Brussels since 1956 and headquartered in Brussels, GBL holds significant stakes in global companies including SGS (14.34%), Pernod Ricard (6.83%), adidas (3.53%), Imerys (54.72%), Umicore (15.92%), Concentrix (13.92%), Ontex (19.98%), GEA Group (0.07%) and TotalEnergies (0.01%); direct private assets encompass controlling stakes in healthcare providers Affidea (99.13%, advanced diagnostics and outpatient services across Europe) and Sanoptis (84.24%, ophthalmology services with operations in Switzerland, Germany, Spain, Italy, Austria and Greece), Canyon (51.31%, direct-to-consumer premium bicycles), plus minority stakes in Voodoo (14.99%, mobile game publishing) and Parques Reunidos (23.00%, European leisure parks); indirect private assets are managed via GBL Capital (funds, co-investments in firms like ICONIQ, Sagard and Backed); third-party asset management includes Sienna Investment Managers (pan-European strategies in listed equities, private equity, credit and venture capital). GBL operates primarily in Europe with additional exposure in North America and Asia-Pacific, targeting industrial, consumer goods, healthcare, digital and business services sectors. Recent developments include portfolio simplification through disposals such as partial SGS stake sale (€772m proceeds, Q1 2025), Umicore shares sale (completed 2025), €1.5bn from GBL Capital assets (announced November 2025, including transfers to Carlyle AlpInvest), and exclusive negotiations to sell Sienna Gestion and Sienna Private Credit to Malakoff Humanis (October 2025); value creation in direct privates with €584m uplift led by Affidea (+€478m, bolstered by €150m GBL equity injection October 2025) and Sanoptis (+€99m); enhanced shareholder returns via €5.00 dividend for FY2024 (+82%, yield 7.6%), ongoing share buybacks (€259m in 9M 2025) and total cash returns of €925m; GBL Capital ceased new commitments; net asset value stands at €14.0bn (€104.83/share) as of September 30, 2025, with liquidity of €4.8bn and LTV 1.8%.